Results 281 to 290 of about 173,203 (312)

Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma

open access: yesCancer Medicine, Volume 14, Issue 21, November 2025.
ABSTRACT Background Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and a leading cause of cancer‐related deaths worldwide. Despite advancements in antiviral therapies for hepatitis B (HBV) and hepatitis C (HCV), HCC incidence continues to rise due to metabolic dysfunction‐associated steatotic liver disease (MASLD), obesity ...
Muhammad Masroor Hussain   +5 more
wiley   +1 more source

Human‐in‐the‐Loop Artificial Intelligence System for Systematic Literature Review: Methods and Validations for the AutoLit Review Software

open access: yesCochrane Evidence Synthesis and Methods, Volume 3, Issue 6, November 2025.
ABSTRACT Introduction While artificial intelligence (AI) tools have been utilized for individual stages within the systematic literature review (SLR) process, no tool has previously been shown to support each critical SLR step. In addition, the need for expert oversight has been recognized to ensure the quality of SLR findings.
Kevin M. Kallmes   +5 more
wiley   +1 more source

Association Between Serum Syndecan 1 Levels and Metabolic Syndrome Parameters: A Comparative Cross‐Sectional Study

open access: yesEndocrinology, Diabetes &Metabolism, Volume 8, Issue 6, November 2025.
The results revealed that men in the MetS+ HTN+ ALT+ group had significantly higher serum SDC1 levels than women (20.19 ± 10.56 vs. 11.82 ± 5.09 ng/mL, p = 0.020). Furthermore, in both the total study sample and the MetS+ HTN+ ALT+ group, SDC1 concentrations were positively correlated with diastolic blood pressure (r = 0.256, p = 0.021; r = 0.463, p ...
Shima Tavalaie   +9 more
wiley   +1 more source

The Effect of Kefir Consumption on Blood Pressure and C‐Reactive Protein: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials

open access: yesEndocrinology, Diabetes &Metabolism, Volume 8, Issue 6, November 2025.
We examined the effects of kefir consumption on blood pressure and C‐reactive protein. Kefir consumption had no significant impact on SBP, DBP and CRP. CRP levels significantly decreased with longer durations of kefir consumption (≥ 8 weeks). ABSTRACT Background Kefir, a traditional fermented milk beverage, has been increasingly promoted for its ...
Elaheh Rashidbeygi   +9 more
wiley   +1 more source

Identification of a Risk-Prediction Model for Hypertension Patients Concomitant with Nonalcoholic Fatty Liver Disease. [PDF]

open access: yesHealthcare (Basel)
Mai X   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy